Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences (VCLS) in 1997, a leading advisor to Biotech, Pharma and Medtech manufacturers for the development, registration and launch of innovative medical technologies across international markets.
Emmanuelle has 30+ years’ experience in drug development. Her expertise lies in non-conventional development strategies. Emmanuelle also provides strategic advice for interacting with FDA and EMA.
Emmanuelle holds a pharmacy degree and was a Resident in the Paris Hospital Authorities (Ancien Interne des Hôpitaux de Paris).
Emmanuelle has published a number of articles. She is a member of the Avicenna Alliance and leads the Policy Development Working Group of the Alliance and is a member of organisations of professionals in Regulatory (Eucope, TOPRA, RAPS, DIA,…).
She is a member of the Advisory Board of AC Immune and serves on the Board of Endodiag.